Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||
| Net Income | -388 | N/A | N/A |
| Depreciation Amortization | 16 | N/A | N/A |
| Accounts receivable | -1 | N/A | N/A |
| Accounts payable and accrued liabilities | 103 | N/A | N/A |
| Other Working Capital | 304 | N/A | N/A |
| Other Operating Activity | -79 | 0 | 0 |
| Operating Cash Flow | $-44 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -4 | N/A | N/A |
| Investing Cash Flow | $-4 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 48 | 0 | 0 |
| Financing Cash Flow | $48 | $N/A | $N/A |
| Net Cash Flow | $0 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -44 | N/A | N/A |
| Capital Expenditure | -4 | N/A | N/A |
| Free Cash Flow | -48 | 0 | 0 |